New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 9, 2013
08:26 EDTMNKD, PFEMannKind future riding on Afrezza prospects, LA Times
The future of MannKind (MNKD) and the fate of its investors is riding on an inhaled form of insulin powder, which Pfizer (PFE) tried in 2006 to market but gave up on after sales failed to meet expectations, said The Los Angeles Times. MannKind hopes to get federal approval for its version, Afrezza, by spring of 2014, the report noted. Reference Link
News For MNKD;PFE From The Last 14 Days
Check below for free stories on MNKD;PFE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 8, 2014
10:03 EDTMNKDOn The Fly: Analyst Initiation Summary
1st United Bancorp (FUBC) initiated with a Neutral at Macquarie... Avista (AVA) initiated with a Fair Value at CRT Capital... Castlight Health (CSLT) initiated with a Neutral at Goldman... Cempra (CEMP) initiated with an Equalweight at Barclays... Coca-Cola (KO) initiated with a Buy at BTIG... JinkoSolar (JKS) initiated with an Overweight at Barclays... Lumenis (LMNS) initiated with a Buy at Goldman... National Retail Properties (NNN) initiated with an Overweight at Morgan Stanley... PepsiCo (PEP) initiated with a Buy at BTIG... Realty Income (O) initiated with an Underweight at Morgan Stanley... Teekay (TK) initiated with an Outperform at Raymond James... Twitter (TWTR) initiated with a Buy at Janney Capital... Realogy (RLGY) initiated with an Outperform at RBC Capital... Bristow Group (BRS) initiated with an Outperform at Clarkson Capital... Era Group (ERA) initiated with an Outperform at Clarkson Capital... Endurance (EIGI) initiated with a Buy at Craig-Hallum... Tutor Perini (TPC) initiated with an Overweight at Stephens... MannKind (MNKD) initiated with an Outperform at Brinson Patrick... TriCo Bancshares (TCBK) initiated with an Outperform at Fig Partners... Achaogen (AKAO) initiated with an Outperform at Cowen.
08:25 EDTMNKDMannKind initiated with an Outperform at Brinson Patrick
Subscribe for More Information
06:27 EDTMNKDStocks with implied volatility below IV index mean; DLLR MNKD
Subscribe for More Information
April 7, 2014
17:28 EDTPFEPfizer sell-off unwarranted, Barron's says
Subscribe for More Information
16:30 EDTMNKDFDA extension of MannKind's Afrezza PDUFA not a surprise, Barron's says
The FDA's decision to extend the Prescription Drug User Fee Act, or PDUFA, for Mankind's Afrezza was not a surprise because of all the information and feedback that the FDA has to incorporate into its approval decision, Barron's reports in its "Stocks to Watch" blog, citing Cowen’s Simos Simeonidis and Yatin Suneja. Reference Link
16:28 EDTPFEOn The Fly: Closing Wrap
Subscribe for More Information
16:01 EDTMNKDOptions Update; April 7, 2014
Subscribe for More Information
12:15 EDTPFEOn The Fly: Midday Wrap
Subscribe for More Information
12:00 EDTMNKDMannKind falls 11.8%
Subscribe for More Information
11:15 EDTMNKD Options with decreasing implied volatility: MNKD GALT DLLR APOL
Subscribe for More Information
10:40 EDTPFEPfizer trades near lows of the day, levels to watch
Subscribe for More Information
10:00 EDTMNKDMannKind falls 11.2%
Subscribe for More Information
09:34 EDTMNKDActive equity options trading on open
Subscribe for More Information
09:10 EDTPFE, MNKDOn The Fly: Pre-market Movers
HIGHER: Questcor (QCOR), up 27% after agreeing to be bought by Mallinckrodt (MNK) for cash, stock valued at $86.10 per Questcor share... Agios Pharmaceuticals (AGIO), up 25% after program shows "promising clinical activity" for advanced blood cancers, shares upgraded at JPMorgan... Vocus (VOCS), up 47% after agreeing to be acquired by GTCR for $446.5M, or $18.00 per share... Pandora (P), up 1.3% following upgrade at Wedbush. LOWER: MannKind (MNKD), down 13% after announcing FDA extension of PDUFA date for Afrezza... American Eagle (AEO), down 2.2% following downgrade at Cowen... Pfizer (PFE), down 2.8% after announcing data for palbociclib in metastatic breast cancer... Mattel (MAT), down 3% following downgrade at BMO Capital... WWE (WWE), down 1.2% after cautious mention in Barron's, company announcing WrestleMania 30 grossed $10.9M.
09:09 EDTPFEConfusion on Pfizer Palbo could create buying opportunity, says BMO Capital
Subscribe for More Information
09:00 EDTMNKDMannKind falls 12.4%
MannKind is down 12.4%, or 85c, to $6.02
09:00 EDTPFEPfizer falls 2.8%
Pfizer is down 2.8%, or 90c, to $31.25
07:27 EDTPFEAmerican Association of Cancer Research to hold annual meeting
Subscribe for More Information
05:51 EDTMNKDMannKind announces FDA extension of PDUFA date for Afrezza
Subscribe for More Information
April 6, 2014
13:46 EDTPFEPfizer's palbociclib significantly prolonged PFS in metastatic breast cancer
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use